| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |